Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to accomplish so might be grounds for compensation. Our lawyers are functioning hard to have those hurt by the drug the compensation they're entitled to.Whilst bleeding is really a common complication linked with anticoagulants, it has been alleged that Xarelto is far more dangerous than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, within the occasion of an emergency, sufferers may be at danger for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.Should you or even a loved 1 suffered a severe bleeding event following taking Xarelto, you might have legal recourse. For much more info, speak to us nowadays to have your case reviewed, cost-free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in situations of death, funeral expenditures. Moreover, they may be seeking punitive damages, that are normally awarded to punish the defendant and deter other organizations from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping xarelto suddenly Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.Visit this page for more details on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, like the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to do so may be grounds for compensation. Our lawyers are operating challenging to acquire these hurt by the drug the compensation they're entitled to.Although bleeding is really a typical complication connected with anticoagulants, it has et xarelto been alleged that Xarelto is much more dangerous than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, patients might be at risk for irreversible bleeding troubles, including life-threatening internal and gastrointestinal hemorrhaging.Should you or even a loved one suffered a significant bleeding event right after taking Xarelto, you might have legal recourse. For a lot more details, make contact with us nowadays to have your case reviewed, free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. Furthermore, they are seeking punitive damages, which are normally awarded to punish the defendant and deter other firms from acting similarly.Why Are Lawsuits Becoming Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a protected anticoagulant option.Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.Visit this page for much more details on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to complete so might be grounds for compensation. Our lawyers are operating challenging to acquire these hurt by the drug the compensation they may be entitled to.Even though bleeding is a typical complication associated with anticoagulants, it has been alleged that Xarelto is far more unsafe than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This means that, in the occasion of an emergency, patients could be at risk for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.If you or even a loved 1 suffered a serious bleeding event after taking Xarelto, you may have legal recourse. For much more information, contact us these days to have your case reviewed, free of charge of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in circumstances of death, funeral expenditures. Additionally, they're seeking punitive damages, that are usually awarded to punish the defendant and deter other companies from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding www.windowsportal.cz higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.Visit this page for a lot more info on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use - and failure click to find out more perform so might be grounds for compensation. Our lawyers are operating challenging to obtain these hurt by the drug the compensation they are entitled to.Whilst bleeding can be a typical complication associated with anticoagulants, it has been alleged that Xarelto is more harmful than classic blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This implies that, in the occasion of an emergency, patients may possibly be at threat for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging.In case you or even a loved 1 suffered a serious bleeding event following taking Xarelto, you may have legal recourse. For much more info, get in touch with us nowadays to possess your case reviewed, totally free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in situations of death, funeral expenses. Furthermore, they may be seeking punitive damages, that are normally awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Being Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a protected anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.Visit this page for a lot more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to complete so could be grounds for compensation. Our lawyers are operating hard to have these hurt by the drug the compensation they may be entitled to.Whilst bleeding is a frequent complication linked with anticoagulants, it has been alleged that Xarelto is far more dangerous than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, within the occasion of an emergency, sufferers could be at risk for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging.In case you or perhaps a loved one particular suffered a serious bleeding event right after taking Xarelto, you might have legal recourse. For a lot more info, speak to us right now to possess your case reviewed, free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. Moreover, they may be looking for punitive damages, that are normally awarded to punish the defendant and deter other companies from acting similarly.Why Are Lawsuits Being Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and health-related staff were not properly pattern-wiki.org made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for a lot more info on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.